Enzo Biochem, Inc. (ENZ)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.2500 |
| Open | 3.2400 |
| Bid | 3.0800 x 800 |
| Ask | 3.8000 x 1200 |
| Day's Range | 3.1800 - 3.3700 |
| 52 Week Range | 2.6100 - 4.8500 |
| Volume | |
| Avg. Volume | 168,066 |
| Market Cap | 160.442M |
| Beta (5Y Monthly) | 0.84 |
| PE Ratio (TTM) | 33.10 |
| EPS (TTM) | 0.1000 |
| Earnings Date | Mar 14, 2022 - Mar 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Corrado Advisors, Llc Buys Innovator Emerging Markets Power Buffer ETF - Octo, Innovator ...
Investment company Corrado Advisors, Llc (Current Portfolio) buys Innovator Emerging Markets Power Buffer ETF - Octo, Innovator International Developed Power Buffer ETF, iShares Core S&P Total U.S.
- GlobeNewswire
Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors
NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfanian and Bradley Radoff to the Company’s Board of Directors (the “Board”), effective immediately. The Company also announced that directors Dov Perlysky and Rebecca Fischer will step down from the Board immediately to facilitate a smooth transition for the new Board members. Dr. Mary Tagliaferri will
- GlobeNewswire
Enzo Biochem Reports First Quarter 2022Â Financial Results and Provides Business Update
1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increaseCompany appoints Hamid Erfanian as Chief Executive Officer Consolidated manufacturing footprint at state-of-the-art Farmingdale, NY campus to enhance operational efficiencies Conference call and live webcast scheduled for today,Wednesday, December 15, 2021 at 4:30 pm (ET) NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company
